In breast cancer, the PD1-PDL1 pathway has been very scarcely studied [33-39]; only two prognostic studies, including 650 cases analyzed at the protein level (immunohistochemistry, IHC) [39] and 398 cases at the mRNA level [36], recently addressed the prognostic issue, but provided divergent results. The gene discussed is CD274; the disease is breast cancer.